期刊文献+

通心络胶囊治疗冠心病心绞痛37例疗效观察 被引量:13

To observe the clinical effect in the treatment of Tongxinluo capsule on 37 cases with angina pectoris of coronary heart disease
下载PDF
导出
摘要 目的:观察通心络胶囊治疗冠心病心绞痛患者的临床疗效。方法:将72例冠心病心绞痛患者随机分成2组,治疗组37例口服通心络胶囊(2粒/次,3次/d),对照组口服丹参片(3片/次,3次/d),疗程均为1个月。结果:在缓解心绞痛症状方面,治疗组总有效率为78.9%,对照组总有效率为75.0%,2组间差异无统计学意义。治疗前后心功能参数及对微循环的影响比较,2组之间差异有统计学意义(P<0.05)。结论:通心络胶囊在缓解心绞痛、改善心功能指数、改善微循环方面效果优于丹参片。 Objective:To observe the clinical effects of tongxinluo capsule in the treatment of patients with angina pectoris of coronary heart disease. Methods :72 cases of pations with angina pectoris of coronary heart disease were randomly divided into two groups. The treatment group of 37 cases with oral administration of Tong-Xin-Luo capsule (2 capsules/ time, 3 times per day) ; and the control group of 35 cases with oral tablet of danshen tablet (3 pieces/ time, 3 times/ day). Both of the treatment course is 1 month. Results: In relieving the angina symptoms, the total effective rate in the treatment group is 78.9% ,and total effective rate is 75% in the control group, There are no significant differences between the two groups. There are significant differences in the "before and after" parameters of cardiac function and influence on microcirculation between the two groups ( P 〈 0. 05 ). Conclusion Tongxinluo capsule in easing angina index, improving microcireulation and heart function has better function than danshen tablet.
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2013年第5期585-585,588,共2页 JOURNAL OF BASIC CHINESE MEDICINE
关键词 通心络胶囊 丹参片 冠心病 心绞痛 疗效观察 Tong-Xin-Luo capsule Danshen Tablet Coronary heart disease Angina peetoris effect
  • 相关文献

参考文献3

二级参考文献12

共引文献58

同被引文献75

  • 1Zhang Q,Lu X N,Sun N L.Effects of Verapamil and Metoprolol on heart rate variability in patients with coronary heart disease[J] .Journal of Peking University,2007,39(6):610-613.
  • 2Wojtkowska I,Tysarowski A,Seliga K,et al.PPAR Gamma expression levels during development of heart failure in patients with coronary artery disease after coronary artery bypass-grafting[J] .PPAR Res,2014:242 790.
  • 3Fox K,Ford I,Steg P G,et al.Ivabradine in stable coronary artery disease without clinical heart failure[J] .N Engl J Med,2014,371(12):1091-1099.
  • 4Melamed R J,Tillmann A,Kufleitner H E,et al.Evaluating the efficacy of an education and treatment program for patients with coronary heart disease[J] .Dtsch Arztebl Int,2014,111(47):802-808.
  • 5Michelle A. Albert,Robert J. Glynn,Julie E. Buring,Paul M. Ridker.Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: A prospective analysis of the Women’s Health Study[J].Atherosclerosis.2007(1)
  • 6John A. Spertus,Ravi Nerella,Richard Kettlekamp,John House,Steve Marso,A Michael Borkon,John S. Rumsfeld.Risk of Restenosis and Health Status Outcomes for Patients Undergoing Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery[J].Circulation.2005(6)
  • 7Salim Yusuf,Srinath Reddy,Stephanie ?unpuu,Sonia Anand.Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization[J].Circulation: Journal of the American Heart Association.2001(22)
  • 8何永生,朱丽萍,严俊珍,古莲香,朱平先.通心络对冠心病稳定型心绞痛患者同型半胱氨酸和临床疗效的影响[J].实用医学杂志,2009,25(7):1124-1126. 被引量:17
  • 9余廷佑.通心络胶囊治疗冠心病心绞痛64例[J].中国实用医刊,2009,36(13):82-83. 被引量:2
  • 10董静莲,高洁,郝瑞.洛丁新联用美托洛尔治疗冠心病合并慢性充血性心力衰竭疗效分析[J].中国中西医结合急救杂志,2009,16(3):189-189. 被引量:7

引证文献13

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部